Ingevity Corp reported second-quarter 2026 results with revenue of $314.1M, net income of $35.3M and diluted EPS of $1 compared with $331.5M, a net loss of ($146.5M) and diluted loss per share of ($4.02) in the year‑ago quarter.Financial Highlights¹ Reported as “Net sales”. ² Reported as “Net incom…
Q2 2026 saw net sales of $314.1M, a 5% decrease year-over-year due to divestitures, but net income from continuing operations improved to $39.8M from a loss last year. Adjusted EBITDA rose to $115M, and the company raised its full-year outlook, expecting $1.05–$1.15B in sales and $380–$400M in adju…
Q2 2026 saw strong growth across all segments (excluding divested units), with adjusted EBITDA up 14% and margins expanding to 36.6%. Full-year guidance was raised for EBITDA, EPS, and free cash flow, supported by robust demand, portfolio transformation, and disciplined capital allocation.Based on…
Q2 2026 saw strong operational execution, with Adjusted EBITDA up 13.9% and EPS up 42.6% year-over-year, despite lower net sales due to a divestiture. Raised full-year guidance reflects robust first-half results, improved margins, and disciplined capital allocation.Original document: Ingevity Corpo…
Ingevity reported second-quarter 2026 results with net sales of $314.1 million and net income from continuing operations of $39.8 million, or $1.13 per diluted share. Adjusted earnings from continuing operations were $61.5 million and adjusted diluted EPS was $1.74, while adjusted EBITDA from conti…
Q2 2026 saw net sales of $314.1M, with adjusted EBITDA up 14% to $115M and margin at 36.6%. The Road Markings divestiture and a $113.2M litigation settlement shaped results, while full-year guidance was raised on strong segment performance and improved leverage.Original document: Ingevity Corporati…
Ingevity Corporation (NYSE: NGVT) today reported its financial results for the second quarter of 2026.The results and guidance in this release include non-GAAP financial measures; see “Use of non‑GAAP financial measures” section for definitions and reconciliations to the most comparable GAAP measur…
Ingevity Corporation (NYSE:NGVT) today announced Evotherm® P35 warm-mix additive has received approval from Germany’s Federal Highway Research Institute, known as BASt, for use in warm-mix asphalt applications. Approval signals that Evotherm® P35 meets the institute’s rigorous requirements, positio…
